Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a simple nerve zap ease period pain? new trial investigates

NCT ID NCT07352982

First seen Jan 27, 2026 · Last updated Jun 22, 2026 · Updated 36 times

Summary

This study tests whether transcutaneous tibial nerve stimulation (TTNS) — a non-invasive nerve stimulation technique — can reduce pain and improve quality of life in women with primary dysmenorrhea (painful periods). Thirty-two women aged 20–25 will receive either TTNS plus standard painkillers or a placebo device plus standard painkillers for three sessions a week over four weeks. The main goal is to measure changes in pain intensity and prostaglandin levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY DYSMENORRHEA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kafrelsheikh University (Faculty of Physical Therapy)

    RECRUITING

    Kafr ash Shaykh, Kafrelsheikh, 33516, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

transcutaneous tibial nerve stimulation (TTNS)

What this could lead to

If it works, this could offer a non-drug option to reduce period pain and improve quality of life for women with primary dysmenorrhea.

What could go wrong

This is a small, early-phase study with only 32 participants. The nerve stimulation may not provide significant pain relief beyond standard care, and results may not apply to all women.

Conditions

The condition(s) this trial relates to.

primary dysmenorrhea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.